Research Papers:
Inhibition of succinate dehydrogenase by the mitochondrial chaperone TRAP1 has anti-oxidant and anti-apoptotic effects on tumor cells
PDF | HTML | Supplementary Files | How to cite
Metrics: PDF 3844 views | HTML 4276 views | ?
Abstract
Giulia Guzzo1, Marco Sciacovelli1,2, Paolo Bernardi1, Andrea Rasola1
1CNR Neuroscience Institute and Department of Biomedical Sciences, University of Padova, 35121 Padova, Italy
2Medical Research Council Cancer Unit, University of Cambridge, Hutchison/MRC Research Centre, Cambridge, United Kingdom
Correspondence to:
Andrea Rasola, e-mail: [email protected]
Keywords: TRAP1, mitochondria, chaperones, cancer metabolism, ROS, succinate dehydrogenase
Received: August 11, 2014 Accepted: September 13, 2014 Published: November 15, 2014
ABSTRACT
TRAP1 is a mitochondrial chaperone highly expressed in many tumor types; it inhibits respiratory complex II, down-modulating its succinate dehydrogenase (SDH) enzymatic activity. SDH inhibition in turn leads to a pseudohypoxic state caused by succinate-dependent HIF1α stabilization and promotes neoplastic growth. Here we report that TRAP1 inhibition of SDH also shields cells from oxidative insults and from the ensuing lethal opening of the mitochondrial permeability transition pore. This anti-oxidant activity of TRAP1 protects tumor cells from death in conditions of nutrient paucity that mimic those encountered in the neoplasm during the process of malignant accrual, and it is required for in vitro tumorigenic growth. Our findings demonstrate that SDH inhibition by TRAP1 is oncogenic not only by inducing pseudohypoxia, but also by protecting tumor cells from oxidative stress.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 2472